Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1801324793
Since 2017
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
211 S 9th St Ste 600
Philadelphia, PA, 19107
Phone (215) 955-1925
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
456 services
Medicare patients, 2024
227
Average age 69
Drug cost, 2024
$1.4M
2,771 prescriptions
Company payments, 2025
$955
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica Watari was code 99214 (office e&m - established), 205 times for 116 patients. In total Jessica Watari billed 456 services in 9 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 205 | 116 | $67.02 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 78 | 68 | $11.44 | $892 |
| 99214 Office E&M - Established | Office | 52 | 36 | $95.32 | $4,957 |
| 99222 Hospital E&M - Initial | Facility | 43 | 43 | $105.08 | $4,518 |
| 99204 Office E&M - New | Facility | 29 | 29 | $95.08 | $2,757 |
| 99213 Office E&M - Established | Facility | 20 | 17 | $45.22 | $904 |
| 99213 Office E&M - Established | Office | 14 | 11 | $72.13 | $1,010 |
By year: 2022 $12K for 141 services; 2023 $26K for 360 services; 2024 $30K for 456 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Watari prescribed most often to Medicare patients was Levothyroxine Sodium, with 281 prescriptions and refills. In total Jessica Watari wrote 2,771 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 281 | 720 | 75 | $54K |
| Trulicity Dulaglutide | 215 | 348 | 43 | $341K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 182 | 430 | 59 | $21K |
| Metformin Hcl Generic | 168 | 485 | 63 | $1,648 |
| Mounjaro Tirzepatide | 126 | 169 | 23 | $179K |
| Ozempic Semaglutide | 119 | 232 | 27 | $222K |
| Glipizide Er Glipizide | 107 | 244 | 25 | $1,913 |
| Metformin Hcl Er Metformin Hcl | 88 | 236 | 33 | $2,115 |
| Methimazole Generic | 84 | 214 | 24 | $851 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 83 | 207 | 36 | $8,722 |
| Jardiance Empagliflozin | 79 | 190 | 25 | $109K |
| Atorvastatin Calcium Generic | 68 | 196 | 23 | $851 |
| Januvia Sitagliptin Phosphate | 67 | 113 | 15 | $57K |
| Novolog Flexpen Insulin Aspart | 61 | 146 | 22 | $15K |
| Rosuvastatin Calcium Generic | 50 | 143 | 18 | $819 |
Brand drugs: 1,375 claims; generic drugs: 1,162 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica Watari $955 ($955 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbott Laboratories with $417.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.